Detalhe da pesquisa
1.
Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.
Blood
; 137(9): 1241-1255, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33027805
2.
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
Neurobiol Dis
; 79: 41-50, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25917763
3.
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
J Neurosci
; 27(9): 2396-402, 2007 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17329437
4.
Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa.
J Histochem Cytochem
; 56(5): 511-6, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18285348
5.
The endocannabinoid system and Alzheimer's disease.
Mol Neurobiol
; 36(1): 75-81, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17952652
6.
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
J Neurol
; 263(7): 1390-400, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27159993
7.
Functional neuroanatomy of the endocannabinoid system.
Pharmacol Biochem Behav
; 81(2): 239-47, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15936805
8.
ß-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors.
Br J Pharmacol
; 166(4): 1474-89, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22321194
9.
The endocannabinoid system and amyloid-related diseases.
Exp Neurol
; 224(1): 66-73, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20353781
10.
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.
Brain Res
; 1283: 148-54, 2009 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19505450